Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis - Wikidata - awgldk - TriplyDB

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

http://www.wikidata.org/entity/Q26851836

about

The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis Intraperitoneal Mesenchymal Cells Promote the Development of Peritoneal Metastasis Partly by Supporting Long Migration of Disseminated Tumor Cells Estrogen receptor alpha is expressed in mesenteric mesothelial cells and is internalized in caveolae upon Freund's adjuvant treatment Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivo Intraoperative peritoneal lavage cytology offers prognostic significance for gastric cancer patients with curative resection Molecular profiling and clinical outcome of high-grade serous ovarian cancer presenting with low- versus high-volume ascites.HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherin Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence.Tumor cell-targeted delivery of nanoconjugated oligonucleotides in composite spheroids Systemic mesenchymal stem cells reduce growth rate of cisplatin-resistant ovarian cancer.An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer.Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis.Evaluation of expansile nanoparticle tumor localization and efficacy in a cancer stem cell-derived model of pancreatic peritoneal carcinomatosis.Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis.Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.Synthetic resveratrol analogue, 3,3',4,4',5,5'-hexahydroxy-trans-stilbene, accelerates senescence in peritoneal mesothelium and promotes senescence-dependent growth of gastrointestinal cancers.CD90+ mesothelial-like cells in peritoneal fluid promote peritoneal metastasis by forming a tumor permissive microenvironment.Heterotypic cellular interactions in the ovarian tumor microenvironment: biological significance and therapeutic implications.Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy.Culture models to define key mediators of cancer matrix remodeling.P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions.Chemokines, chemokine receptors and the gastrointestinal system.Review: Cell Dynamics in Malignant Pleural Effusions.Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma.Upregulation of BNIP3 mediated by ERK/HIF-1α pathway induces autophagy and contributes to anoikis resistance of hepatocellular carcinoma cells.Insulin-Like Growth Factors and Their Binding Proteins in Tumors and Ascites of Ovarian Cancer Patients: Association With Response To Neoadjuvant Chemotherapy Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.The peritoneum: healing, immunity, and diseases.Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance.Morcellating uterine mesenchymal tumors: The pathologist's view.Highly Specific and Sensitive Fluorescent Nanoprobes for Image-Guided Resection of Sub-Millimeter Peritoneal Tumors.High-Pressure Nebulization as Application Route for the Peritoneal Administration of siRNA Complexes.Studies on assessment methods of malignant ascites residue and changes of verapamil concentration in intraperitoneal perfusion chemotherapy.miR-145 promoted anoikis resistance in tumor endothelial cells.Flow cytometric quantification of intraperitoneal free tumor cells in patients with peritoneal metastasis.

P2860

Q26783022-6A5D8D0F-3ED5-4860-B076-A283C7F78716 Q27311973-3C7B28C3-C88B-42C6-89B7-A47FCBFFA312 Q28535149-A2FD2A0A-362E-4405-A433-1FD7621BBDA6 Q28545949-15BB01AD-AAFA-40A6-A5D8-1086169651A9 Q33738960-3921F743-DED2-48EF-B1CB-F08DDE3E2844 Q33748623-6B92A1C3-B11F-49A8-9AD0-B81728A3758F Q33927161-3A54ADF4-1658-4DF9-9618-C93C28E6F95C Q34100895-067F4E6F-4600-452C-9420-B0DF1E54E7F1 Q34606502-7B9CBEEA-B8A9-4F49-BD07-517BD62E6BAE Q35042364-6A08955A-BD74-45A6-AEB9-1E424DB19FD1 Q35109003-0E9A7905-5FDF-4C78-941B-8D91019F7AC9 Q35931850-F5ACF741-3682-4FCA-9049-9B96C6D82BF3 Q36358324-CFF93849-D9E7-47D2-801A-EB993DF8067D Q36813016-60EE1B42-C974-43AD-B46F-ACDC9ED89526 Q37013343-84D03556-79CA-4676-8197-FFF405D367B2 Q37034828-79A27CFD-117A-4AF5-B0EC-1395A9607284 Q37196532-42361BAE-578B-483D-8915-4A75FD02A703 Q37295543-659B98C1-E048-41B7-ADE7-2D35C68FF043 Q37375475-C30F552D-C926-438F-9CAA-BBFD3C6481C1 Q37500419-A0267AB2-82CB-4E40-A2C7-26DE96CCC549 Q37559209-2633C80D-89B7-4613-BB5E-4159F169CAD0 Q37589245-2DD4E7D3-1E43-4E64-804A-442B8A692A32 Q37676502-E038B546-AA9E-4DD3-8255-3A68BC7D8B71 Q37707040-6C690C8C-8C40-49EC-81E6-25024BF0FFEA Q38109160-757F3F69-266C-4C38-AC47-6B93AA1665F1 Q38247899-8EE93647-6260-49C6-B41A-280046DC1532 Q38747175-010BDF20-0ADA-4B87-9C25-3FAAD1126494 Q38942433-1775A698-3227-448F-BF24-FB7F645EDBFC Q38972661-B7B0A2B6-E5E6-406A-BFA7-E91FD6A7EDF7 Q38997171-13B97E6E-2E66-4CE0-A1A5-8A7069C0004D Q39082233-05ACD027-6197-4C6E-BBC4-37F2DD099918 Q39129504-9C72F716-0D3E-4841-B27F-F8C311999085 Q39443675-ACE6B9EE-1FF6-4C0B-B5D6-585FCEB0332B Q41009718-31211C0C-95CD-4635-A21C-F64477489E3F Q46039016-00D63D07-89AC-45B9-BDB1-B6B2AC8C0225 Q47111181-B1A47632-FACB-4A8C-A59A-7780FFE3D7C0 Q48762735-D6758641-4FC5-40D9-942E-6F06A40F0BAC Q53501359-C2E48143-595D-4592-8723-00844A1A085E Q53740013-67A7F850-486E-4C18-AD23-1B7780B5E390 Q54783467-4A5CE1A8-F2AB-4BEB-BF13-8DA2D3D27BD7

P2860

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

http://www.wikidata.org/entity/Q26851836

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

@ast

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

@en

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

@nl

type

label

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

@ast

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

@en

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

@nl

prefLabel

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

@ast

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

@en

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

@nl

P1433

Q26851836-355FE234-FBC6-48E1-B989-31F409BDAC82

P1476

Q26851836-0320B1CB-8FE2-4BDA-B021-6D09EFE79FDF

P2093

Q26851836-1F2A41FB-5354-4BFF-924A-B67BCD993386

Q26851836-299D5752-52AE-42D1-90F4-56E814AC70CD

Q26851836-34BD3B65-7D88-43B1-9A48-ABF9FF04F7FB

Q26851836-ADA1203B-15A2-4CF2-B3B3-FDDB8D1F9A03

P2860

Q26851836-00D1A4E8-2FF0-4A16-BE5B-371E7510AEE9

Q26851836-029DA7BC-C6FB-4D29-B1E7-A3A7BA86F7D1

Q26851836-0C350347-75AA-496C-A44F-08943CECA861

Q26851836-0CEB7AB2-33EC-4F0C-B37F-00F8075B8912

Q26851836-0EFE866F-D9FB-4362-A218-BDFCCC0AC318

Q26851836-106B6AE3-CE84-4F0B-BAA7-D0A5805D0B0E

Q26851836-131E0BDB-4CCE-419B-A989-07AE1E1DFAC3

Q26851836-1700944E-1859-490D-B7F6-0345996F8065

Q26851836-17975B7B-3F64-47C9-BAE5-909A149ACCB1

Q26851836-1990622C-2F6D-4A35-82BD-AA10BE43DA42

P2888

Q26851836-DDBE0780-E85F-4D0E-B770-E1C0EEEF59DB

P304

Q26851836-64518FA1-01DD-46A8-AE9D-CA1A452A5308

P31

Q26851836-340C45F6-2FB5-42A7-9E3C-2FB9411FEDDC

Q26851836-A1E1B4D9-D0C5-479E-8776-169CB37FAF99

P3181

Q26851836-C2B543F8-89FA-4280-ADEC-2197A01E2C8B

P356

Q26851836-E627A207-F3AE-44E4-8192-042B84458D4B

P407

Q26851836-DF0BCCC6-5B9A-42B5-BF19-AB2BF2BE2EC2

P433

Q26851836-BEE8AA2E-AC00-47B9-94FB-B464699BB3A7

P478

Q26851836-25FC198A-5443-4373-8A79-01846368D41C

P577

Q26851836-1F05CE84-0562-4318-AE2E-4383051377BF

Q26851836-6E24FA74-455B-4752-B0CB-0777964FB324

P5875

Q26851836-24355347-BA20-49B3-81D0-E42CEDE73698

P6179

Q26851836-62EFC4B2-22A3-4C93-A38A-6DFDB8484D6E

P698

Q26851836-3CCEC1EF-E458-40D6-B179-7D560C00085A

P921

Q26851836-593D4E9B-9425-4767-9968-D0CCA28909A5

Q26851836-7BBAFBB6-64AB-4F7B-B76A-B0A9C4A1CFC6

Q26851836-BE50A397-618E-42F8-9694-745AD7E3EDA1

P932

Q26851836-143533A3-0BB9-41C7-8189-FFAC6B651117

P3181

P356

S10555-012-9351-2

P1433

Cancer and Metastasis Reviews

P1476

Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis

@en

P2093

K. Joan Murphy

http://www.w3.org/2001/XMLSchema#string

Katharine L. Sodek

http://www.w3.org/2001/XMLSchema#string

Maurice J. Ringuette

http://www.w3.org/2001/XMLSchema#string

Theodore J. Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Palliative surgery versus medical management for bowel obstruction in ovarian cancer

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

Micro-RNA-21 regulates TGF-β-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction

Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer

Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth

Matrix crosslinking forces tumor progression by enhancing integrin signaling

A cancer cell metalloprotease triad regulates the basement membrane transmigration program

Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC)

Differential regulation of adhesion complex turnover by ROCK1 and ROCK2

Cancer statistics, 2012

P2888

s10555-012-9351-2

P304

397-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1908855

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S10555-012-9351-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224820356

http://www.w3.org/2001/XMLSchema#string

P6179

1047802189

http://www.w3.org/2001/XMLSchema#string

P698

22527451

http://www.w3.org/2001/XMLSchema#string

P921

peritoneal carcinoma

peritoneal neoplasm

P932

3350631

http://www.w3.org/2001/XMLSchema#string